The United States speciality generics market is experiencing robust growth, driven by increasing demand for affordable healthcare solutions, rising incidences of chronic diseases, and advancements in healthcare technologies. In 2023, the market size was valued at almost USD 64.06 billion, and it is projected to grow at a compound annual growth rate